BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 29279949)

  • 21. A competing risk nomogram to predict severe late toxicity after modern re-irradiation for squamous carcinoma of the head and neck.
    Ward MC; Lee NY; Caudell JJ; Zajichek A; Awan MJ; Koyfman SA; Dunlap NE; Zakem SJ; Hassanzadeh C; Marcrom S; Boggs DH; Isrow D; Vargo JA; Heron DE; Siddiqui F; Bonner JA; Beitler JJ; Yao M; Trotti AM; Riaz N;
    Oral Oncol; 2019 Mar; 90():80-86. PubMed ID: 30846182
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Attitudes, practices and perspectives on imaging strategies in prostate cancer: a national cross-sectional survey involving expert radiation oncologists on behalf of AIRO (Italian association of radiotherapy and clinical oncology) GU group.
    Lucchini R; Francolini G; Matrone F; Timon G; Franzese C; Marvaso G; Borghetti P; Nicosia L; Trodella LE; Vinciguerra A; Jereczek-Fossa BA; Arcangeli S
    Med Oncol; 2021 Nov; 39(1):3. PubMed ID: 34739613
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Simultaneous integrated boost intensity-modulated radiotherapy for locally advanced head-and-neck squamous cell carcinomas: II--clinical results.
    Lauve A; Morris M; Schmidt-Ullrich R; Wu Q; Mohan R; Abayomi O; Buck D; Holdford D; Dawson K; Dinardo L; Reiter E
    Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):374-87. PubMed ID: 15380569
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Technical guidelines for head and neck cancer IMRT on behalf of the Italian association of radiation oncology - head and neck working group.
    Merlotti A; Alterio D; Vigna-Taglianti R; Muraglia A; Lastrucci L; Manzo R; Gambaro G; Caspiani O; Miccichè F; Deodato F; Pergolizzi S; Franco P; Corvò R; Russi EG; Sanguineti G;
    Radiat Oncol; 2014 Dec; 9():264. PubMed ID: 25544268
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Safety and efficacy of hypofractionated stereotactic body reirradiation in head and neck cancer: Long-term follow-up of a large series.
    Kress MA; Sen N; Unger KR; Lominska CE; Deeken JF; Davidson BJ; Newkirk KA; Hwang J; Harter KW
    Head Neck; 2015 Oct; 37(10):1403-9. PubMed ID: 24824359
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Curative treatment of head and neck squamous cell carcinoma : Organ preservation strategies in clinical routine in German-speaking countries.
    Kurzweg T; Kimmeyer J; Knecht R; Hoffmann TK; Busch CJ; Lörincz BB; Schuler PJ; Laban S
    HNO; 2016 Jul; 64(7):501-7. PubMed ID: 27357174
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adjuvant Chemoradiation After Surgical Resection in Elderly Patients With High-Risk Squamous Cell Carcinoma of the Head and Neck: A National Cancer Database Analysis.
    Woody NM; Ward MC; Koyfman SA; Reddy CA; Geiger J; Joshi N; Burkey B; Scharpf J; Lamarre E; Prendes B; Adelstein DJ
    Int J Radiat Oncol Biol Phys; 2017 Jul; 98(4):784-792. PubMed ID: 28602410
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The PROCAINA (PROstate CAncer INdication Attitudes) Project (Part I): a survey among Italian radiation oncologists on postoperative radiotherapy in prostate cancer.
    Alongi F; De Bari B; Franco P; Ciammella P; Chekrine T; Livi L; Jereczek-Fossa BA; Filippi AR;
    Radiol Med; 2013 Jun; 118(4):660-78. PubMed ID: 23358818
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Re-irradiation for head and neck squamous cell carcinoma.
    Benson R; Giridhar P; Venkatesulu BP; Mallick S; Raza MW; Rath GK
    J Egypt Natl Canc Inst; 2017 Mar; 29(1):1-9. PubMed ID: 27595192
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recurrent and second primary squamous cell carcinoma of the head and neck: when and how to reirradiate.
    Strojan P; Corry J; Eisbruch A; Vermorken JB; Mendenhall WM; Lee AW; Haigentz M; Beitler JJ; de Bree R; Takes RP; Paleri V; Kelly CG; Genden EM; Bradford CR; Harrison LB; Rinaldo A; Ferlito A
    Head Neck; 2015 Jan; 37(1):134-50. PubMed ID: 24481720
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Re-Irradiation Therapy for Locally Recurrent Head and Neck Cancer: A National Survey of Practice Patterns.
    Rwigema JM; Choi J; Lee NY; Heron DE; Chen AM
    Cancer Invest; 2017 Jul; 35(6):393-402. PubMed ID: 28437131
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Radiation Oncology--New Approaches in Squamous Cell Cancer of the Head and Neck.
    Margalit DN; Schoenfeld JD; Tishler RB
    Hematol Oncol Clin North Am; 2015 Dec; 29(6):1093-106. PubMed ID: 26568550
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic factors and selection criteria in the retreatment of head and neck cancers.
    May ME; Cash ED; Silverman CL; Redman RA; Perez CA; Wilson LD; Tennant PA; Bumpous JM; Dunlap NE
    Oral Oncol; 2019 Jan; 88():85-90. PubMed ID: 30616802
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intensity-modulated radiation treatment for head-and-neck squamous cell carcinoma--the University of Iowa experience.
    Yao M; Dornfeld KJ; Buatti JM; Skwarchuk M; Tan H; Nguyen T; Wacha J; Bayouth JE; Funk GF; Smith RB; Graham SM; Chang K; Hoffman HT
    Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):410-21. PubMed ID: 16168834
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Patterns of failure after reirradiation with intensity-modulated radiation therapy and the competing risk of out-of-field recurrences.
    Margalit DN; Rawal B; Catalano PJ; Haddad RI; Goguen LA; Annino DJ; Limaye SA; Lorch JH; Lavigne AW; Schoenfeld JD; Sher DJ; Tishler RB
    Oral Oncol; 2016 Oct; 61():19-26. PubMed ID: 27688100
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reirradiation for recurrent head and neck carcinoma using high-dose-rate brachytherapy: A multi-institutional study.
    Yamazaki H; Masui K; Suzuki G; Yoshida K; Nakamura S; Isohashi F; Kotsuma T; Takaoka Y; Tanaka E; Akiyama H; Ishibashi N
    Brachytherapy; 2022; 21(3):341-346. PubMed ID: 35307301
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Patterns of care analysis for head & neck cancer of unknown primary site: a survey inside the German society of radiation oncology (DEGRO).
    Müller von der Grün J; Bon D; Rödel C; Balermpas P
    Strahlenther Onkol; 2018 Aug; 194(8):750-758. PubMed ID: 29761228
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of spatially fractionated radiotherapy (GRID) and definitive chemoradiotherapy with curative intent for locally advanced squamous cell carcinoma of the head and neck: initial response rates and toxicity.
    Peñagarícano JA; Moros EG; Ratanatharathorn V; Yan Y; Corry P
    Int J Radiat Oncol Biol Phys; 2010 Apr; 76(5):1369-75. PubMed ID: 19625138
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Radiotherapy for head and neck cancer in Lombardy: a survey by the Lombardy Group of the Italian Association for Radiation Oncology.
    Merlotti A; Di Muzio N; Antognoni P; Filippone F; Bianchi E; Castiglioni S; Bruschieri L; Ivaldi G; De Cicco L; Marzoli L; Orecchia R
    Tumori; 2015; 101(5):560-5. PubMed ID: 25983103
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neoadjuvant chemotherapy for locally advanced head and neck squamous cell carcinoma - Is it still relevant? A practice pattern survey among oncologists of India.
    Bandyopadhyay A; Goswami U; Ghosh P; Das P; Mandal S
    J Cancer Res Ther; 2023; 19(5):1316-1323. PubMed ID: 37787301
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.